-
1
-
-
0032874698
-
Nonepileptic uses of gabapentin
-
Magnus L. Nonepileptic uses of gabapentin. Epilepsia 1999;40 (Suppl 6):S66-S72
-
(1999)
Epilepsia
, vol.40
, Issue.SUPPL. 6
-
-
Magnus, L.1
-
2
-
-
0013113677
-
Antiepileptic drugs
-
Gelder MG, Lopez-Ibor JJ, Andreasen N, editors, 1st ed. New York: Oxford University Press
-
Palmer CM, Pope HG Jr. Antiepileptic drugs. In: Gelder MG, Lopez-Ibor JJ, Andreasen N, editors. New Oxford Textbook of Psychiatry. Vol. 2, 1st ed. New York: Oxford University Press, 2000:1326-1333
-
(2000)
New Oxford Textbook of Psychiatry. Vol. 2, 1st Ed.
, vol.2
, pp. 1326-1333
-
-
Palmer, C.M.1
Pope H.G., Jr.2
-
3
-
-
0013066918
-
Other anticonvulsants
-
Sadock BJ, Sadock VA, editors, Philadelphia: Lippincott Williams and Wilkins
-
Susman N. Other anticonvulsants. In: Sadock BJ, Sadock VA, editors. Comprehensive Textbook of Psychiatry. Vol.2, 7th ed. Philadelphia: Lippincott Williams and Wilkins, 2000:2299-2303
-
(2000)
Comprehensive Textbook of Psychiatry. Vol. 2, 7th Ed.
, vol.2
, pp. 2299-2303
-
-
Susman, N.1
-
4
-
-
0029795902
-
The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine
-
Singh L, Field M, Ferris P, Hunter JC, Oles RJ, Williams RG ve ark. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology (Berl) 1996;127:1-9
-
(1996)
Psychopharmacology (Berl)
, vol.127
, pp. 1-9
-
-
Singh, L.1
Field, M.2
Ferris, P.3
Hunter, J.C.4
Oles, R.J.5
Williams, R.G.6
-
6
-
-
0035191623
-
Gabapentin: A unique anti-epileptic agent
-
Dougherty JA, Rhoney DH. Gabapentin: a unique anti-epileptic agent. Neurol Res 2001;23:821-829
-
(2001)
Neurol Res
, vol.23
, pp. 821-829
-
-
Dougherty, J.A.1
Rhoney, D.H.2
-
7
-
-
0002168997
-
New anticonvulsants in bipolar disorders: Lamotrigine, gabapentin, tiagabine
-
Trimble M, Schmitz B, editors. Guilford: Clarius Press
-
Walden J, Grunze H. New anticonvulsants in bipolar disorders: lamotrigine, gabapentin, tiagabine. In: Trimble M, Schmitz B, editors. Seizures, Affective Disorders and Anticonvulsant Drugs. Guilford: Clarius Press, 2002:131-142
-
(2002)
Seizures, Affective Disorders and Anticonvulsant Drugs
, pp. 131-142
-
-
Walden, J.1
Grunze, H.2
-
8
-
-
0031785310
-
Gabapentin; antiepileptic mechanism of action
-
Kelly KM. Gabapentin; antiepileptic mechanism of action. Neuropsychobiology 1998;38:139-144
-
(1998)
Neuropsychobiology
, vol.38
, pp. 139-144
-
-
Kelly, K.M.1
-
9
-
-
0033595496
-
Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders
-
Ketter TA, Post RM, Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999;53 (Suppl 2):S53-S67
-
(1999)
Neurology
, vol.53
, Issue.SUPPL. 2
-
-
Ketter, T.A.1
Post, R.M.2
Theodore, W.H.3
-
10
-
-
0032477305
-
Gabapentin for the treatment of postherpatic neuralgia: A randomized controlled trial
-
Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpatic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-1842
-
(1998)
JAMA
, vol.280
, pp. 1837-1842
-
-
Rowbotham, M.1
Harden, N.2
Stacey, B.3
Bernstein, P.4
Magnus-Miller, L.5
-
11
-
-
0032477294
-
Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial
-
Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;280:1831-1836
-
(1998)
JAMA
, vol.280
, pp. 1831-1836
-
-
Backonja, M.1
Beydoun, A.2
Edwards, K.R.3
Schwartz, S.L.4
Fonseca, V.5
Hes, M.6
LaMoreaux, L.7
Garofalo, E.8
-
12
-
-
0030938675
-
Gabapentin for idiopathic trigeminal neuralgia: Report of two cases
-
Sist T, Filadora V, Miner M, Lema M. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology 1997;48:1467
-
(1997)
Neurology
, vol.48
, pp. 1467
-
-
Sist, T.1
Filadora, V.2
Miner, M.3
Lema, M.4
-
13
-
-
0028999227
-
Gabapentin in the management of reflex sympathetic dystrophy
-
Mellick GA, Mellick LB. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage 1995;10:265-266
-
(1995)
J Pain Symptom Manage
, vol.10
, pp. 265-266
-
-
Mellick, G.A.1
Mellick, L.B.2
-
14
-
-
0033911715
-
Gabapentin in the prophylaxis of migraine: A double-blind randomized placebo-controlled study
-
Di Trapani G, Mei D, Marra C, Mazza S, Capuano A. Gabapentin in the prophylaxis of migraine: A double-blind randomized placebo-controlled study. Clin Ther 2000;151:145-148
-
(2000)
Clin Ther
, vol.151
, pp. 145-148
-
-
Di Trapani, G.1
Mei, D.2
Marra, C.3
Mazza, S.4
Capuano, A.5
-
15
-
-
0035097928
-
Efficacy of gabapentin in migraine prophylaxis
-
Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadon N, Stacey B, Tepper S. Efficacy of gabapentin in migraine prophylaxis. Headache 2001;41:119-128
-
(2001)
Headache
, vol.41
, pp. 119-128
-
-
Mathew, N.T.1
Rapoport, A.2
Saper, J.3
Magnus, L.4
Klapper, J.5
Ramadon, N.6
Stacey, B.7
Tepper, S.8
-
16
-
-
0036144265
-
Emerging uses of the new anticonvulsants: What's the state of evidence?
-
Curtis JL. Emerging uses of the new anticonvulsants: what's the state of evidence? Formulary 2002;37:24-31
-
(2002)
Formulary
, vol.37
, pp. 24-31
-
-
Curtis, J.L.1
-
17
-
-
0000445509
-
Effectiveness of gabapentin in various movement disorders
-
Adler CH. Effectiveness of gabapentin in various movement disorders. Mov Disord 1996;11:251
-
(1996)
Mov Disord
, vol.11
, pp. 251
-
-
Adler, C.H.1
-
18
-
-
0030898703
-
Treatment of restless legs syndrome with gabapentin
-
Adler CH. Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol 1997;20:148-151
-
(1997)
Clin Neuropharmacol
, vol.20
, pp. 148-151
-
-
Adler, C.H.1
-
19
-
-
0000141458
-
Open-label trial of gabapentin periodic limb movements disorder of sleep
-
Ehrenberg BL, Muller-Schwarze A, Frankel F. Open-label trial of gabapentin periodic limb movements disorder of sleep. Neurology 1997;48:278
-
(1997)
Neurology
, vol.48
, pp. 278
-
-
Ehrenberg, B.L.1
Muller-Schwarze, A.2
Frankel, F.3
-
20
-
-
0031009672
-
A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus
-
Averbuch-Heller L, Tusa RJ, Fuhry L, Rottach KG, Ganser GL, Heide W, Buttner U, Leigh RJ. a double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997;41:818-825
-
(1997)
Ann Neurol
, vol.41
, pp. 818-825
-
-
Averbuch-Heller, L.1
Tusa, R.J.2
Fuhry, L.3
Rottach, K.G.4
Ganser, G.L.5
Heide, W.6
Buttner, U.7
Leigh, R.J.8
-
21
-
-
0029099710
-
Gabapentin for behavioral dyscontrol
-
Ryback R, Ryback L. Gabapentin for behavioral dyscontrol. Am J Psychiatry 1995;152:1399
-
(1995)
Am J Psychiatry
, vol.152
, pp. 1399
-
-
Ryback, R.1
Ryback, L.2
-
22
-
-
0034969555
-
Gabapentin for behavioral dyscontrol with mental retardation
-
Bozikas V, Bascialla F, Yulis P, Savvidou I, Karavatos A. Gabapentin for behavioral dyscontrol with mental retardation. Am J Psychiatrry 2001; 158:965-966
-
(2001)
Am J Psychiatrry
, vol.158
, pp. 965-966
-
-
Bozikas, V.1
Bascialla, F.2
Yulis, P.3
Savvidou, I.4
Karavatos, A.5
-
23
-
-
0035095821
-
Gabapentin for treatment of behavioral and psychological symptoms of dementia
-
Miller LJ. Gabapentin for treatment of behavioral and psychological symptoms of dementia. Ann Pharmacother 2001;35:427-431
-
(2001)
Ann Pharmacother
, vol.35
, pp. 427-431
-
-
Miller, L.J.1
-
24
-
-
0031029401
-
Gabapentin in the treatment of bipolar disorder
-
Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolar disorder. Am J Psychiatry 1997;154:291-292
-
(1997)
Am J Psychiatry
, vol.154
, pp. 291-292
-
-
Schaffer, C.B.1
Schaffer, L.C.2
-
27
-
-
0030813131
-
Acute treatment of bipolar depression with gabapentin
-
Young LT, Robb JC, Patelis-Siotis L, Mac Donald C, Joffe RT. Acute treatment of bipolar depression with gabapentin. Biol Psychiatry 1997; 42:851-853
-
(1997)
Biol Psychiatry
, vol.42
, pp. 851-853
-
-
Young, L.T.1
Robb, J.C.2
Patelis-Siotis, L.3
Mac Donald, C.4
Joffe, R.T.5
-
28
-
-
0032168304
-
An open label study of gabapentin in the treatment of acute mania
-
Erfurth A, Kammerer C, Grunze H, Normann C, Walden J. An open label study of gabapentin in the treatment of acute mania. J Psychiatr Res 1998; 32:261-264
-
(1998)
J Psychiatr Res
, vol.32
, pp. 261-264
-
-
Erfurth, A.1
Kammerer, C.2
Grunze, H.3
Normann, C.4
Walden, J.5
-
29
-
-
0033188208
-
Gabapentin in the acute treatment of refractory bipolar disorder
-
Altshuler LL, Keck PE Jr, McElroy SL, Suppes T, Brown ES, Denicoff K, Frye M, Gitlin M, Hwang S, Goodman R, Leverich G, Nolen W, Kupka R, Post R. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord 1999;1:61-65
-
(1999)
Bipolar Disord
, vol.1
, pp. 61-65
-
-
Altshuler, L.L.1
Keck P.E., Jr.2
McElroy, S.L.3
Suppes, T.4
Brown, E.S.5
Denicoff, K.6
Frye, M.7
Gitlin, M.8
Hwang, S.9
Goodman, R.10
Leverich, G.11
Nolen, W.12
Kupka, R.13
Post, R.14
-
30
-
-
0034278763
-
Gabapentin in bipolar disorder: A placebo controlled trial of adjunctive therapy
-
Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo controlled trial of adjunctive therapy. Bipolar Disord 2000;2:249-255
-
(2000)
Bipolar Disord
, vol.2
, pp. 249-255
-
-
Pande, A.C.1
Crockatt, J.G.2
Janney, C.A.3
Werth, J.L.4
Tsaroucha, G.5
-
31
-
-
0032721368
-
Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment
-
Schaffer CB, Schaffer LC. Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment. J Affect Disord 1999; 55:237-240
-
(1999)
J Affect Disord
, vol.55
, pp. 237-240
-
-
Schaffer, C.B.1
Schaffer, L.C.2
-
32
-
-
0033697737
-
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
-
Frye M, Ketterer TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Cora-Ocatelli G, Leverich GS, Post RM. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20:607-614
-
(2000)
J Clin Psychopharmacol
, vol.20
, pp. 607-614
-
-
Frye, M.1
Ketterer, T.A.2
Kimbrell, T.A.3
Dunn, R.T.4
Speer, A.M.5
Osuch, E.A.6
Luckenbaugh, D.A.7
Cora-Ocatelli, G.8
Leverich, G.S.9
Post, R.M.10
-
33
-
-
0036238952
-
Third generation anticonvulsants in bipolar disorder: A review of efficacy and summary of clinical recommendations
-
Yatham LN, Kusumakar V, Calabrese JR, Rao R, Scarrow G, Kroeker G. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations. J Clin Psychiatry 2002; 63:275-283
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 275-283
-
-
Yatham, L.N.1
Kusumakar, V.2
Calabrese, J.R.3
Rao, R.4
Scarrow, G.5
Kroeker, G.6
-
34
-
-
0036894686
-
Effectiveness of adjunctive gabapentin in resistant bipolar disorder: Is it due to anxious-alcohol abuse comorbidity
-
Perugi G, Toni C, Frare F, Ruffolo G, Moretti L, Torti C, Akiskal HS. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: Is it due to anxious-alcohol abuse comorbidity. J Clin Psychopharmacol 2002;22:584-591
-
(2002)
J Clin Psychopharmacol
, vol.22
, pp. 584-591
-
-
Perugi, G.1
Toni, C.2
Frare, F.3
Ruffolo, G.4
Moretti, L.5
Torti, C.6
Akiskal, H.S.7
-
36
-
-
0036137829
-
Treatment of alcohol withdrawal with gabapentin
-
Bozikas V, Petrikis P, Gamvrula K, Savvidou I, Karavatos A. Treatment of alcohol withdrawal with gabapentin. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:197-199
-
(2002)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.26
, pp. 197-199
-
-
Bozikas, V.1
Petrikis, P.2
Gamvrula, K.3
Savvidou, I.4
Karavatos, A.5
-
37
-
-
0031727322
-
Gabapentin: Long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety related disorders
-
Chouinard G, Beauclair L, Belanger MC. Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety related disorders. Can J Psychiatry 1998; 43:305
-
(1998)
Can J Psychiatry
, vol.43
, pp. 305
-
-
Chouinard, G.1
Beauclair, L.2
Belanger, M.C.3
-
38
-
-
0031802463
-
Gabapentin as a potential treatment for anxiety disorders
-
Pollack MH, Matthews J, Scott EL. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry 1998; 155:992-993
-
(1998)
Am J Psychiatry
, vol.155
, pp. 992-993
-
-
Pollack, M.H.1
Matthews, J.2
Scott, E.L.3
-
39
-
-
0032789136
-
Treatment of social phobia with gabapentin: A placebo-controlled study
-
Pande AC, Davidson JR, Jefferson JW, Janney CA, Katzelnick CA, Weisler RH, Greist JH, Sutherland SM. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 1999; 19:341-348
-
(1999)
J Clin Psychopharmacol
, vol.19
, pp. 341-348
-
-
Pande, A.C.1
Davidson, J.R.2
Jefferson, J.W.3
Janney, C.A.4
Katzelnick, C.A.5
Weisler, R.H.6
Greist, J.H.7
Sutherland, S.M.8
-
40
-
-
0033942108
-
Placebo-controlled study of gabapentin treatment of panic disorder
-
Pande AC, Pollack MH, Crockatt MA, Greiner M, Chouinard G, Lydiard RB, Taylor CB, Dager SR, Shiovitz T. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 2000; 20:467-471
-
(2000)
J Clin Psychopharmacol
, vol.20
, pp. 467-471
-
-
Pande, A.C.1
Pollack, M.H.2
Crockatt, M.A.3
Greiner, M.4
Chouinard, G.5
Lydiard, R.B.6
Taylor, C.B.7
Dager, S.R.8
Shiovitz, T.9
-
41
-
-
0013066920
-
Anxiety disorders: Biochemical aspects
-
Sadock BJ, Sadock VA, editors. Philadelphia: Lippincott Williams and Wilkins
-
Sullivan GM, Coplan JD. Anxiety disorders: Biochemical aspects. In: Sadock BJ, Sadock VA, editors. Comprehensive Textbook of Psychiatry Vol.1. 7th ed. Philadelphia: Lippincott Williams and Wilkins, 2000:1450-1456
-
(2000)
Comprehensive Textbook of Psychiatry. Vol. 1. 7th Ed.
, vol.1
, pp. 1450-1456
-
-
Sullivan, G.M.1
Coplan, J.D.2
-
42
-
-
0034060807
-
Gabapentin treatment for posttraumatic stress disorder
-
Brannon N, Labbate L, Huber M. Gabapentin treatment for posttraumatic stress disorder. Can J Psychiatry 2000;45:84
-
(2000)
Can J Psychiatry
, vol.45
, pp. 84
-
-
Brannon, N.1
Labbate, L.2
Huber, M.3
-
43
-
-
0035145903
-
Benzodiazepines and anticonvulsants for social phobia (Social anxiety disorder)
-
Jefferson JW. Benzodiazepines and anticonvulsants for social phobia (Social anxiety disorder). J Clin Psychiatry 2001;62(suppl 1):S50-S53
-
(2001)
J Clin Psychiatry
, vol.62
, Issue.SUPPL. 1
-
-
Jefferson, J.W.1
-
45
-
-
0021994719
-
Gabapentin decreases monoamine release without affecting acetylcholine release in the brain
-
Schlicker E, Reimann W, Gothert M. Gabapentin decreases monoamine release without affecting acetylcholine release in the brain. Arzneimittelfirsschung 1985;35:1347-1349
-
(1985)
Arzneimittelfirsschung
, vol.35
, pp. 1347-1349
-
-
Schlicker, E.1
Reimann, W.2
Gothert, M.3
-
46
-
-
0035675912
-
Gabapentin in PTSD: A retrospective, clinical series of adjunctive therapy
-
Hamner MB, Brodrick PS, Labbate LA. Gabapentin in PTSD: A retrospective, clinical series of adjunctive therapy. Ann Clin Psychiatry 2001;13:141-146
-
(2001)
Ann Clin Psychiatry
, vol.13
, pp. 141-146
-
-
Hamner, M.B.1
Brodrick, P.S.2
Labbate, L.A.3
|